259 related articles for article (PubMed ID: 35469617)
1. Anaphylaxis to Excipients in Current Clinical Practice: Evaluation and Management.
Bruusgaard-Mouritsen MA; Nasser S; Garvey LH; Krantz MS; Stone CA
Immunol Allergy Clin North Am; 2022 May; 42(2):239-267. PubMed ID: 35469617
[TBL] [Abstract][Full Text] [Related]
2. Hidden Dangers: Recognizing Excipients as Potential Causes of Drug and Vaccine Hypersensitivity Reactions.
Caballero ML; Krantz MS; Quirce S; Phillips EJ; Stone CA
J Allergy Clin Immunol Pract; 2021 Aug; 9(8):2968-2982. PubMed ID: 33737254
[TBL] [Abstract][Full Text] [Related]
3. Anaphylaxis to intravenous paracetamol containing povidone. A case report and narrative review of excipient allergy related to anaesthesia.
Preuss JF; Goddard CE; Clarke RC; Platt PR; Sadleir PH
Anaesth Intensive Care; 2020 Sep; 48(5):404-408. PubMed ID: 33016081
[TBL] [Abstract][Full Text] [Related]
4. Biologic excipients: Importance of clinical awareness of inactive ingredients.
Ionova Y; Wilson L
PLoS One; 2020; 15(6):e0235076. PubMed ID: 32584876
[TBL] [Abstract][Full Text] [Related]
5. Steroid Allergy: Clinical Features and the Importance of Excipient Testing in a Diagnostic Algorithm.
Li PH; Wagner A; Thomas I; Watts TJ; Rutkowski R; Rutkowski K
J Allergy Clin Immunol Pract; 2018; 6(5):1655-1661. PubMed ID: 29408496
[TBL] [Abstract][Full Text] [Related]
6. Carboxymethylcellulose excipient allergy: a case report.
Townsend K; Laffan J; Hayman G
J Med Case Rep; 2021 Nov; 15(1):565. PubMed ID: 34819140
[TBL] [Abstract][Full Text] [Related]
7. The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach.
Greenhawt M; Abrams EM; Shaker M; Chu DK; Khan D; Akin C; Alqurashi W; Arkwright P; Baldwin JL; Ben-Shoshan M; Bernstein J; Bingemann T; Blumchen K; Byrne A; Bognanni A; Campbell D; Campbell R; Chagla Z; Chan ES; Chan J; Comberiati P; Dribin TE; Ellis AK; Fleischer DM; Fox A; Frischmeyer-Guerrerio PA; Gagnon R; Grayson MH; Horner CC; Hourihane J; Katelaris CH; Kim H; Kelso JM; Lang D; Ledford D; Levin M; Lieberman J; Loh R; Mack D; Mazer B; Mosnaim G; Munblit D; Mustafa SS; Nanda A; Oppenheimer J; Perrett KP; Ramsey A; Rank M; Robertson K; Sheikh J; Spergel JM; Stukus D; Tang MLK; Tracy JM; Turner PJ; Whalen-Browne A; Wallace D; Wang J; Waserman S; Witry JK; Worm M; Vander Leek TK; Golden DBK
J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3546-3567. PubMed ID: 34153517
[TBL] [Abstract][Full Text] [Related]
8. Anaphylaxis Due to the Excipient Polysorbate 80.
Palacios Castaño MI; Venturini Díaz M; Lobera Labairu T; González Mahave I; Del Pozo Gil MD; Blasco Sarramián A
J Investig Allergol Clin Immunol; 2016; 26(6):394-396. PubMed ID: 27996954
[No Abstract] [Full Text] [Related]
9. COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia.
Tunbridge M; Perkins G; Lee M; Salehi T; Ryoo D; Kette F; Smith W; Gold M; Le TA; Yuson C; Hissaria P
Intern Med J; 2022 Nov; 52(11):1884-1890. PubMed ID: 35848521
[TBL] [Abstract][Full Text] [Related]
10. First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.
Wolfson AR; Robinson LB; Li L; McMahon AE; Cogan AS; Fu X; Wickner P; Samarakoon U; Saff RR; Blumenthal KG; Banerji A
J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3308-3320.e3. PubMed ID: 34166844
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical excipients. Adverse effects associated with inactive ingredients in drug products (Part I).
Golightly LK; Smolinske SS; Bennett ML; Sutherland EW; Rumack BH
Med Toxicol Adverse Drug Exp; 1988; 3(2):128-65. PubMed ID: 3287089
[TBL] [Abstract][Full Text] [Related]
12. Anaphylaxis to trometamol excipient in gadolinium-based contrast agents for clinical imaging.
Lukawska J; Mandaliya D; Chan AWE; Foggitt A; Bidder T; Harvey J; Stycharczuk L; Bisdas S
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):1086-1087. PubMed ID: 30217530
[No Abstract] [Full Text] [Related]
13. Anaphylactic reaction to povidone secondary to drug ingestion in a young child.
Michavila-Gomez AV; Moreno-Palanques MA; Ferrer-Vazquez M; Ferriols-Leisart R; Bartolomé B
Allergol Immunopathol (Madr); 2012; 40(4):259-61. PubMed ID: 21996435
[No Abstract] [Full Text] [Related]
14. Excipients as Potential Agents of Anaphylaxis in Vaccines: Analyzing the Formulations of Currently Authorized COVID-19 Vaccines.
Caballero ML; Quirce S
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):92-93. PubMed ID: 33433387
[No Abstract] [Full Text] [Related]
15. Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach.
Greenhawt M; Dribin TE; Abrams EM; Shaker M; Chu DK; Golden DBK; Akin C; Anagnostou A; ALMuhizi F; Alqurashi W; Arkwright P; Baldwin JL; Banerji A; Bégin P; Ben-Shoshan M; Bernstein J; Bingemann TA; Bindslev-Jensen C; Blumenthal K; Byrne A; Cahill J; Cameron S; Campbell D; Campbell R; Cavender M; Chan ES; Chinthrajah S; Comberiati P; Eastman JJ; Ellis AK; Fleischer DM; Fox A; Frischmeyer-Guerrerio PA; Gagnon R; Garvey LH; Grayson MH; Isabwe GAC; Hartog N; Hendron D; Horner CC; Hourihane JO; Iglesia E; Kan M; Kaplan B; Katelaris CH; Kim H; Kelso JM; Khan DA; Lang D; Ledford D; Levin M; Lieberman JA; Loh R; Mack DP; Mazer B; Mody K; Mosnaim G; Munblit D; Mustafa SS; Nanda A; Nathan R; Oppenheimer J; Otani IM; Park M; Pawankar R; Perrett KP; Peter J; Phillips EJ; Picard M; Pitlick M; Ramsey A; Rasmussen TH; Rathkopf MM; Reddy H; Robertson K; Rodriguez Del Rio P; Sample S; Sheshadri A; Sheik J; Sindher SB; Spergel JM; Stone CA; Stukus D; Tang MLK; Tracy JM; Turner PJ; Vander Leek TK; Wallace DV; Wang J; Wasserman S; Weldon D; Wolfson AR; Worm M; Yacoub MR
J Allergy Clin Immunol; 2023 Aug; 152(2):309-325. PubMed ID: 37295474
[TBL] [Abstract][Full Text] [Related]
16. Delayed Hypersensitivity Reactions Caused by Drug Excipients: A Literature Review.
Caballero ML; Quirce S
J Investig Allergol Clin Immunol; 2020; 30(6):400-408. PubMed ID: 32376520
[TBL] [Abstract][Full Text] [Related]
17. Excipients in medicinal products used in gastroenterology as a possible cause of side effects.
Ursino MG; Poluzzi E; Caramella C; De Ponti F
Regul Toxicol Pharmacol; 2011 Jun; 60(1):93-105. PubMed ID: 21354240
[TBL] [Abstract][Full Text] [Related]
18. AstraZeneca ChAdOx1-S COVID-19 vaccine can be safely administered in patients with EDTA allergy.
Ali SB; Perkins G; Ryoo D; Lee M; Tunbridge M; Yuson C; Smith W; Hissaria P; Le TT
Allergy Asthma Clin Immunol; 2022 Mar; 18(1):22. PubMed ID: 35272714
[TBL] [Abstract][Full Text] [Related]
19. Allergy to COVID-19 vaccines: A current update.
Cabanillas B; Novak N
Allergol Int; 2021 Jul; 70(3):313-318. PubMed ID: 33962863
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical Industry Perspective on the Non-Clinical Evaluation of Novel Excipients: Results From an Industry Survey Conducted by the IQ Novel Excipient Working Group.
Giffen PS; Buckley LA; Pinkstaff J
Int J Toxicol; 2023 Dec; 42(6):480-488. PubMed ID: 37450849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
